47 results
424B3
CHRS
Coherus Biosciences Inc
26 Jul 23
Prospectus supplement
4:59pm
, as applicable (including each company’s ability to achieve strategic goals, objectives and targets over applicable periods), industry performance
S-4/A
CHRS
Coherus Biosciences Inc
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
and uncertainties relating to Coherus’ or Surface’s business, as applicable (including each company’s ability to achieve strategic goals, objectives
S-4
CHRS
Coherus Biosciences Inc
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
to achieve strategic goals, objectives and targets over applicable periods), industry performance, general business and economic conditions.
The COVID-19
425
rjukiq3ocm8u8se71pp
16 Jun 23
Business combination disclosure
5:17pm
425
uj1qng27g6i
16 Jun 23
Business combination disclosure
5:16pm
425
0ei7vh3f
16 Jun 23
Business combination disclosure
5:14pm
425
elrtb7
16 Jun 23
Business combination disclosure
5:14pm
425
7ac7b35 fghre83zhwb
16 Jun 23
Business combination disclosure
5:12pm
425
6wiaattyr6shtid
16 Jun 23
Business combination disclosure
5:11pm
425
eh1z71cdb8 7kpugqmxz
16 Jun 23
Business combination disclosure
8:08am
425
em79n0x5l19fjrp
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-99.1
ci0704x3 yqg
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
5vbp4lpnnk
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
h2f avykb
8 Nov 21
Coherus BioSciences Reports Third Quarter 2021 Results
4:06pm